Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 1 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recs

0
Player Avatar rwpaules (96.11) Submitted: 7/10/2012 7:37:05 AM : Outperform Start Price: $4.07 ALXA Score: +22.39

Adasuve PDUFA date Dec 21, 2012

Featured Broker Partners


Advertisement